Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

March 3, 2022

Rural Life as a Wheelchair User

  • Access to Care
    /
  • Additional MS resource sites
    /
   This story is for everyone who wonders about how wheelchair users live their best lives outside the urban landscape…
Access to Care

March 2, 2022

#ACTRIMS2022 – Ublituximab Eases Brain Lesions Better Than Aubagio

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
 The experimental medication Ublituximab significantly reduces the number of new brain lesions with severe nerve cell degeneration in people with relapsing multiple…
MS Drug Therapies

February 23, 2022

Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
 Hina Khan 1, Fareeha Khalid Ghori 1, Uzma Ghani 1, Aneela Javed 1, Saadia Zahid 2 Affiliations expand PMID: 35182322   DOI: 10.1007/s11033-022-07223-5 Abstract Multiple sclerosis (MS) is a chronic and complex…
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

February 23, 2022

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study

  • MS Research Study and Reports
    /
Pascal Benkert 1, Stephanie Meier 2, Sabine Schaedelin 1, Ali Manouchehrinia 3, Özgür Yaldizli 2, Aleksandra Maceski 2, Johanna Oechtering…
MS Research Study and Reports

February 23, 2022

Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders

  • MS Research Study and Reports
    /
Read complete article here Abstract Background: B cells can contribute to immune-mediated disorders. Targeting CD20 has proved to be efficacious in…
MS Research Study and Reports

February 20, 2022

What Happens if Multiple Sclerosis Goes Untreated?

  • Multiple Sclerosis
    /
 Multiple sclerosis drugs have been proved to reduce relapses. But some with MS still say no to treatment. By Becky…
Multiple Sclerosis

February 17, 2022

Multiple Sclerosis: Fatigue

  • Multiple Sclerosis (MS) Symptoms
    /
  Fatigue in people with multiple sclerosis is very real, although the reason it occurs is not clear. MS patients…
Multiple Sclerosis (MS) Symptoms

February 15, 2022

Frequently Asked Questions ( FAQ’s ) : Generic, Biologic and Biosimilar – Medications

  • MS Drug Therapies
    /
February   2022 What is a generic medication? A generic medication is a product that is equivalent to a brand-name medication whose patent protections…
MS Drug Therapies

February 13, 2022

Tevogen Bio™ to Study Potential Use of its T cell Technology in Epstein-Barr Virus and Multiple Sclerosis

  • MS Research Study and Reports
    /
 January 20, 2022 04:26 PM Eastern Standard Time METUCHEN, N.J.–(BUSINESS WIRE)–Tevogen Bio, a clinical stage biotechnology company specializing in cell…
MS Research Study and Reports

February 11, 2022

Study: DNA Methylation in T-cells Affected by MS and Its Treatments

  • MS Research Study and Reports
    /
by Marisa Wexler MS | February 1, 2022 Multiple sclerosis (MS) is characterized by changes in methylation — a type…
MS Research Study and Reports

Categories

Latest Blog Posts